2008 ◽  
Vol 39 (01) ◽  
Author(s):  
U Gruber-Sedlmayr ◽  
M Brunner-Krainz ◽  
E Sorantin ◽  
W Sauseng ◽  
B Plecko

2014 ◽  
Vol 69 (8) ◽  
pp. 870-879 ◽  
Author(s):  
A.R. Hart ◽  
M.F. Smith ◽  
E.H. Whitby ◽  
S. Alladi ◽  
S. Wilkinson ◽  
...  

Author(s):  
Antonio Y. Hardan ◽  
Lawrence K. Fung ◽  
Thomas Frazier ◽  
Sean W. Berquist ◽  
Nancy J. Minshew ◽  
...  

2001 ◽  
Vol 12 (2) ◽  
pp. 82-90 ◽  
Author(s):  
Margret Hund-Georgiadis ◽  
David G. Norris ◽  
Thomas Guthke ◽  
D. Yves von Cramon

1995 ◽  
Vol 37 (3) ◽  
pp. 198-206 ◽  
Author(s):  
K. G. Go ◽  
R. L. Kamman ◽  
E. L. Mooyaart ◽  
M. A. A. M. Heesters ◽  
J. Pruim ◽  
...  

1990 ◽  
Vol 72 (5) ◽  
pp. 763-766 ◽  
Author(s):  
Kiyohiro Houkin ◽  
Ingrid L. Kwee ◽  
Tsutomu Nakada

✓ Serial proton (1H) and phosphorus-31 (31P) magnetic resonance (MR) spectroscopy of cerebral infarction was performed in rats to assess the sensitivity of these techniques for use in clinical cerebral infarction. In this experimental chronic infarction model, 31P spectroscopy tended to return to a “normal” pattern within 24 hours after induction of infarction in spite of pathologically proven completed infarction and, therefore, appeared not to be sensitive enough for clinical application. On the other hand, proton spectroscopy invariably showed persistent high lactate levels and was capable of distinguishing completed infarction from reperfused recovered brain. Persistent high lactate levels appear to be a good MR spectroscopic indicator of completed infarction.


1997 ◽  
Vol 40 (1) ◽  
pp. 36-46 ◽  
Author(s):  
R. J. S. Chinn ◽  
I. D. Wilkinson ◽  
M. A. Hall-Craggs ◽  
M. N. J. Paley ◽  
E. Shortall ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document